Both in Pharmaceuticals
Johnson & Johnson vs Vertex Pharmaceuticals
Over the past year JNJ returned +46.7% and VRTX returned +31.2%; their daily moves had a correlation of 0.40.
JNJ +46.7% VRTX +31.2%Growth of $1, one year, split-adjusted
| Metric | JNJ | VRTX |
|---|---|---|
| Price | $273.20 | $558.88 |
| Market cap | $657.68B | $141.65B |
| Today | −0.73% | +3.50% |
| 1 month | +5.6% | +10.3% |
| 6 months | +20.3% | +31.8% |
| Year to date | +32.0% | +23.3% |
| 1 year | +46.4% | +34.0% |
| Revenue growth (YoY) | +5.9% | +12.5% |
| Gross margin | 68.1% | 85.3% |
| Net margin | 0.8% | 33.0% |
| P/E (TTM) | 40.9× | 32.2× |
| Price / sales | 6.6× | 11.3× |
| Net cash | -$27.42B | $7.85B |
| Dividend yield | 1.96% | — |
| Volatility (60d) | 23.4% | 28.7% |
| Short % of float | 0.7% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).